Advances in nano-drug delivery systems for targeting therapy of breast cancer
Journal of Pharmacy and Pharmacology · 2026
DOI: 10.1093/jpp/rgag068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Yi Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: Henan Medical Science and Technology Joint Building Program.
Abstract (Originalsprache)
Background
Breast cancer is the most common malignant tumor among women worldwide, and conventional chemotherapy faces major challenges including poor targeting, severe systemic toxicity, and drug resistance.
Objective
This review analyzes the application of nano-drug delivery systems (NDDS) in improving breast cancer chemotherapy, with a particular focus on recent advances in nanocarrier-based targeting strategies.
Methods
This review systematically outlines the current epidemiology and clinical treatment landscape of breast cancer, and provides a detailed analysis of various drug delivery systems (e.g., liposomes, polymeric micelles, inorganic nanoparticles) and their targeting mechanisms, including passive, active, and physicochemical-responsive targeting.
Results
NDDS enhance tumor-selective uptake and therapeutic efficacy while reducing side effects, especially active-targeting systems modified with small-molecule ligands such as biotin. Furthermore, NDDS can circumvent multidrug resistance by inhibiting efflux pumps and modulating the tumor microenvironment.
Conclusion
Nano-drug delivery systems represent a promising disease-modifying approach for precise breast cancer treatment, though challenges remain in clinical translation, which may be overcome through interdisciplinary collaboration and systematic optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Zhengzhou Immuno Bio-Tech Co., Ltd, Zhengzhou 450061, China.
- Department of Orthopedics, The First Affiliated Hospital of Henan Polytechnic University (the Second People's Hospital of Jiaozuo City), Jiaozuo 454001, China.
ORCID-Profile: Yi Zhao
Förderung
- Henan Medical Science and Technology Joint Building Program
Zitieren
APA
Zhao, Y., Cui, Y., & Zhao, Z. (2026). Advances in nano-drug delivery systems for targeting therapy of breast cancer. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag068
Vancouver
Zhao Y, Cui Y, Zhao Z. Advances in nano-drug delivery systems for targeting therapy of breast cancer. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgag068
BibTeX
@article{Zhao2026,
author = {Zhao, Yi and Cui, Yamin and Zhao, Ze},
title = {Advances in nano-drug delivery systems for targeting therapy of breast cancer},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
doi = {10.1093/jpp/rgag068}
}
EUVIMED